I'd say any acquisition will be a TRP type as that is derma focused (or close) as a scar tissue cream and on shelves but selling while phase 3 still needs to be done.
MC is only $9.9m so affordable and in our wheelhouse.
That said, I don't think we'll do any takeover/acquisition until well and truly CF+ and Sofdra is selling without the need of so many salesmen (they can then move onto another product launch)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $588.2M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 31.0¢ | 30.0¢ | $2.131M | 7.020M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 504695 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 38124 | 3 |
View Market Depth
| Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
| BOT (ASX) Chart |